NIH-funded research R01 grant

Telemedicine for Opioid Treatment: Expanding Access and Quality

Official title: Telemedicine for Treatment of Opioid Use Disorder

Funded at Harvard Medical School · NIH-11382469 · Data updated 2026-11-12

This project looks at how telemedicine helps people with opioid use disorder get evidence-based care, using real-world data from Medicare, Medicaid, private insurance, and pharmacy claims.

More Opioid Use research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionHarvard Medical School
NIH-funded
Lab location1 site (Boston, United States)
Project startJuly 1, 2019
Project endMay 31, 2028
Funding year2026
Award (this year)$734,565
NIH project number5R01DA048533-07
Project IDNIH-11382469 on NIH RePORTER

Who could benefit from this research

Could help

Adults 21 years and older with opioid use disorder who may be treated by telemedicine services or interact with dispensing pharmacies.

Less likely to help

Individuals without OUD or those not using or considering telemedicine for OUD may not directly benefit.

What this research studies

This grant studies how virtual treatment approaches for opioid use disorder are being used in real-world settings and what outcomes patients experience. It will compare fully virtual clinicians to traditional ones, explore the usefulness of audio-only telemedicine, and examine how pharmacy dispensing of buprenorphine affects patient outcomes. The work will use large national datasets to identify patterns and inform policy and payer decisions to improve access and quality of care. The findings aim to guide clinicians, policymakers, and insurers in optimizing tele-OUD delivery. The project continues to build on prior research showing telemedicine’s growing role in OUD treatment.

Why it matters

Potential benefit: If successful, it could improve access to effective OUD care through telemedicine and inform policies that support high-quality, convenient treatment.

How similar studies have gone: Prior studies have documented growth and quality issues in tele-OUD; this renewal aims to clarify outcomes and policy impacts in real-world settings.

Where this research is happening

  • Harvard Medical School
    Boston, United States
    Active

Researchers

  • Principal investigator: Huskamp, Haiden a — Harvard Medical School
  • Study coordinator: Huskamp, Haiden a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.